EFFICACY AND SAFETY OF TENOFOVIR ALAFENAMIDE (TAF) AT 2 YEARS IN CHILDREN AND ADOLESCENTS WITH CHRONIC HEPATITIS B (CHB)

Schwarz, Kathleen B; Bezerra, Jorge A; Sokal, Etienne

EFFICACY AND SAFETY OF TENOFOVIR ALAFENAMIDE (TAF) AT 2 YEARS IN CHILDREN AND ADOLESCENTS WITH CHRONIC HEPATITIS B (CHB)

Schwarz, Kathleen B

;

Bezerra, Jorge A

;

Sokal, Etienne

;et.al.

(2023) AASLD LIVER MEETING — Location: Boston, USA (9.November.2023)

Files

abstract1414.pdf

Open Access
Adobe PDF
1.49 MB

Download

Details

Authors

Schwarz, Kathleen B
Author
Bezerra, Jorge A
Author
Sokal, EtienneUCLouvain
Author
et. al.

Abstract

Enclosed

Affiliations

UCLouvainSSS/IREC/PEDI - Pôle de Pédiatrie
UCLouvain(SLuc) Service de gastro-entérologie et hépatologie pédiatrique

Citations

APA
Chicago
FWB

Schwarz, K. B., Bezerra, J. A., Sokal, E., & et al. (2023). EFFICACY AND SAFETY OF TENOFOVIR ALAFENAMIDE (TAF) AT 2 YEARS IN CHILDREN AND ADOLESCENTS WITH CHRONIC HEPATITIS B (CHB). Hepatology, 78(S1), S1-S2154 ABSTRACT 1414-C. https://hdl.handle.net/2078.5/100631 (Original work published 2023)